| 000 | 01298 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517022336.0 | ||
| 264 | 0 | _c20160824 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1873-7560 | ||
| 024 | 7 |
_a10.1016/j.eururo.2015.02.043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGroenendijk, Floris H | |
| 245 | 0 | 0 |
_aReply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014. _h[electronic resource] |
| 260 |
_bEuropean urology _cAug 2015 |
||
| 300 |
_ae33-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aUrinary Bladder Neoplasms |
| 700 | 1 | _aFransen van de Putte, Elisabeth E | |
| 700 | 1 | _avan Rhijn, Bas W G | |
| 700 | 1 | _aBernards, René | |
| 700 | 1 | _avan der Heijden, Michiel S | |
| 773 | 0 |
_tEuropean urology _gvol. 68 _gno. 2 _gp. e33-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2015.02.043 _zAvailable from publisher's website |
| 999 |
_c24713047 _d24713047 |
||